Delivery Order SPE2DB22D2009-SPE2DB25FL8SA
Award Date
4/7/25
Potential Completion Date
4/8/25
Potential Value
$6.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $29,730.64 and a period of performance through February 28, 2025. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a delivery order awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of REXULTI 2 MG TABLET 30S, a prescription medication. The contract has a ceiling value of $3,928.00 and a completion date of September 27, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REXULTI 1 MG TABLET 30S, a prescription medication, with a ceiling value of $2,655.96 and a period of performance through August 13, 2024. The contract was awarded on August 12, 2024 and is a firm fixed-price, delivery order contract with no set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of REXULTI 2 MG TABLET 30S, a prescription medication, with a firm fixed price ceiling value of $14,752.73 and a period of performance through March 24, 2025. The contract is not designated as a set-aside and represents an Indefinite Delivery Contract (IDC) vehicle that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $56,834.34, is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of July 3, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $1,952.20 and a completion date of March 7, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation indicated. AmerisourceBergen holds a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REXULTI 0.5 MG TABLET 30S. The contract has a ceiling value of $30,712.23 and a completion date of February 14, 2025. It is a firm fixed-price contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a $6,945.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REXULTI 2 MG TABLET 30S, a pharmaceutical product, with a period of performance through April 4, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
This is a $15,157.99 firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of REXULTI 2 MG TABLET 30S, a prescription medication. This delivery order is part of a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REXULTI 0.5 MG TABLET 30S, a prescription medication. The award has a firm fixed price, a ceiling value of $6,103.11, and an ultimate completion date of June 5, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...